|
NAUT Nautilus Biotechnology Inc 1808805 |
| Balance Sheet |
|
Current Assets
|
144,205,000 |
|
Assets
|
259,704,000 |
|
Current Liabilities
|
8,662,000 |
|
Liabilities
|
36,270,000 |
|
Equity
|
223,434,000 |
|
Shares Out
|
125,411,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-44,836,000 |
|
Investing Cash Flow
|
29,144,000 |
| Market Analysis |
Market Cap
|
358,676,018 |
|
Price
|
1.93 |
|
BVPS
|
1.78 |
|
PB
|
1.08 |
|
EPS
|
-0.56 |
|
PS
|
2.87 |
|
FCF
|
-15,692,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAUT documents filed with the SEC.
NAUT Filings
Clear
